Prevalence, Risk Factors and Vaccine Response against Hepatitis B in People Aged 50 Years or Older

Prevalence, Risk Factors and Vaccine Response against Hepatitis B in People Aged 50 Years or Older

Universal immunization against hepatitis B has contributed to reducing incidence of the disease, but older individuals remain susceptible to acquiring the hepatitis B virus worldwide. Thus, this study aimed to investigate the epidemiology of HBV infection in individuals aged 50 years and over in cen...

Full description

Bibliographic Details
Main Authors: Luana Rocha da Cunha Rosa, Leyla Gabriela Verner Amaral Brandão, Winny Éveny Alves Moura, Lays Rosa Campos, Grécia Carolina Pessoni, Juliana de Oliveira Roque e Lima, José Cássio de Moraes, Megmar Aparecida dos Santos Carneiro, Sheila Araújo Teles, Karlla Antonieta Amorim Caetano
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Vaccines
Subjects:
hepatitis B vaccines
middle aged
elderly
epidemiology
immunogenicity vaccine
Online Access:https://www.mdpi.com/2076-393X/11/3/597

Internet

https://www.mdpi.com/2076-393X/11/3/597

Similar Items